Drug intelligence / Profile preview

Pediatric Hepatitis B Vaccine (Keymen İlaç)

Development stage: Unknown
Lead developer: Heber Biotec
Modality: Vaccines & Immunotherapeutics
Administration: Intramuscular

Overview

The Pediatric Hepatitis B Vaccine from Keymen İlaç (a subsidiary of Alagöz Holding) is an approved biologic vaccine indicated for the prevention of Hepatitis B virus (HBV) infection in pediatric populations. Keymen İlaç has been a significant supplier of vaccines to the Turkish market for nearly 50 years, providing over 700 million doses of various vaccines. This specific vaccine is designed to elicit a protective immune response against HBV, helping to prevent the development of chronic hepatitis, cirrhosis, and hepatocellular carcinoma associated with the virus. It is part of the company's portfolio of essential vaccines supplied to the Turkish Ministry of Health.

Brand names: Pediyatrik Tip Hepatit B Aşısı
Other names: Pediatric Hepatitis B VaccineHepatitis B Vaccine (Pediatric)

Beyond the preview

Go deeper on Pediatric Hepatitis B Vaccine (Keymen İlaç).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pediatric Hepatitis B Vaccine (Keymen İlaç).